Ophthalmology

Cheaper AMD drug could lead to serious eye issues

A Queen's University study of two eye drugs used to treat wet Age-related Macular Degeneration (AMD) has determined the cheaper of the two could lead to eye inflammation, a potentially blinding adverse effect.

Alzheimer's disease & dementia

Experts challenge FDA over approval for new dose of Alzheimer's drug

Approval for a new dose of a best-selling Alzheimer's drug "breached the FDA's own regulatory standard" and has led to "incomplete and distorted messages" about the drug, warn experts in the British Medical Journal today.

Health

America hits the brakes on health care spending

Is health-care relief finally in sight? Health spending stabilized as a share of the nation's economy in 2010 after two back-to-back years of historically low growth, the government reported Monday.

Medications

Older pills often safer; many think new is better

Many consumers mistakenly believe new prescription drugs are always safer than those with long track records, and that only extremely effective drugs without major side effects win government approval, according to a new ...

Addiction

Survey finds majority support for drug checking services

Data from the 2019 National Drug Strategy Household Survey examined support for drug checking services, analyzing between demographic, social, and substance use variables and the endorsement of drug checking.

Addiction

U.S. opioid crisis best viewed as a connected ecosystem

The nation's opioid crisis, which kills thousands of Americans annually, is best viewed as an ecosystem where all parts of the vexing problem are interconnected, underscoring the need for holistic solutions that address the ...

Medications

Texans back easing state restrictions on marijuana

Texans overwhelmingly support proposals to ease state restrictions on both the medical and recreational use of marijuana, with 82% supportive of legislation that would legalize marijuana for a wide range of medical treatments.

page 17 from 22